Amgen, Inc. (AMGN) Posts Solid Q3 Results; Boosts Buyback to $10B; Raises FY11 EPS Guidance
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $344.72 +2.11%
EPS Growth %: -7.1%
Financial Fact:
Operating income: 2.53B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -7.1%
Financial Fact:
Operating income: 2.53B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amgen, Inc. (NASDAQ: AMGN) reported Q3 EPS of $1.40, $0.10 better than the analyst estimate of $1.30. Revenue for the quarter came in at $3.94 billion versus the consensus estimate of $3.87 billion.
Raised its buyback program to $10 billion.
Amgen, Inc. sees FY2011 EPS of $5.15-$5.30, versus prior guidance of $5.00-$5.20 and the consensus of $5.21. Amgen, Inc. sees FY2011 revenue of $15.4-$15.6 billion, versus prior guidance of $15.1-$15.5 billion and the consensus of $15.43 billion.
Raised its buyback program to $10 billion.
Amgen, Inc. sees FY2011 EPS of $5.15-$5.30, versus prior guidance of $5.00-$5.20 and the consensus of $5.21. Amgen, Inc. sees FY2011 revenue of $15.4-$15.6 billion, versus prior guidance of $15.1-$15.5 billion and the consensus of $15.43 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook
- Safe Bulkers (SB) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
